• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 464477 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1413856931 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1413856931 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Shares of Acadia Pharmaceuticals Rise Above Previous 52-Week High

Published on Thu, 03/21/2013 - 14:10
By Mallory Stone

Shares of Acadia Pharmaceuticals (NASDAQ:ACAD) traded today at $8.70, breaking its 52-week high. So far today approximately 18.6 million shares have been exchanged, as compared to an average 30-day volume of 1.3 million shares.

In the past 52 weeks, Acadia Pharmaceuticals share prices have been bracketed by a low of $1.29 and a high of $8.70 and are now at $8.67, 572% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 2.3% while the 50-day MA has advanced 1.6%.

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs for the treatment of central nervous system disorders. The company is currently working on the treatment of induced dysfunction in Parkinson's disease ,schizophrenia, neuropathic pain and glaucoma.

Acadia Pharmaceuticals (NASDAQ:ACAD) is currently priced 3.1% above its average consensus analyst price target of $8.40. The stock should find initial support at its 50-day moving average (MA) of $6.02 and further support at its 200-day MA of $3.35.

By Mallory Stone
mstone@fnno.com

Latest News from FNNO

Tenaris: The Losing Streak Continues (TS...

Tenaris (NYSE:TS) traded at a new 52-week low today of $37.56. This new low was reache ...

Shares of TECO Energy Rise Above Previou...

TECO Energy (NYSE:TE) traded today at a new 52-week high of $18.78. This new high was ...

Shares of Teck Resources Fall to a New 5...

Teck Resources (NYSE:TCK) traded today at a new 52-week low of $15.15. This new low wa ...

Strayer Education Looks to Continue to T...

Strayer Education (NASDAQ:STRA) traded at a new 52-week high today of $67.03. Approxim ...

Shares of Sonic Rise to a New 52-Week Hi...

Sonic (NASDAQ:SONC) traded at a new 52-week high today of $24.00. This new high was re ...

Shares of Cia Siderurgica Nacional Fall ...

Cia Siderurgica Nacional (NYSE:SID) traded today at a new 52-week low of $3.32. Approx ...

Shares of Steven Madden Fall Below Previ...

Shares of Steven Madden (NASDAQ:SHOO) traded today at $28.02, breaking its 52-week low. ...

Shares of SAP Fall to a New 52-Week Low...

SAP (NYSE:SAP) traded today at a new 52-week low of $64.10. Approximately 2.3 million ...